Heart failure and COPD study for patients aged 50 to 70
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial looks at how heart failure with preserved pumping function affects people who also have COPD. It aims to understand the course of the disease and long-term outlook.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of COPD.
- You are currently hospitalized for COPD.
- You are a citizen of the Russian Federation.
- You are between 50 and 70 years old.
- You agree to take part in the study.
- You do not have other chronic diseases that are active or worsening, or any mental disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether combined heart and lung checks can improve COPD management. If you have COPD and a heart condition, the results may help doctors better tailor your treatment.
This study looks at the health of Brazilian adults with COPD. It aims to understand how the condition affects people and may help improve future treatments.
This study tests whether the heart medication metoprolol can help people who have both heart failure with reduced pumping function and COPD (a lung condition). It aims to see if the drug is safe and effective for this combination of conditions.
This study looks at how COPD affects your breathing and heart health. It is for people who are newly diagnosed with COPD and have a history of smoking.
This study looks at people who have both COPD (a long-term lung condition) and a heart problem. The goal is to learn more about how these two conditions affect each other and to help doctors provide better care.
This trial looks at how the heart and lungs work together during a severe COPD flare-up that requires hospital care. It may help doctors find better ways to treat breathing problems in the ICU.
Hear when a new COPD (Chronic Obstructive Pulmonary Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.